Sergey G. Arkhipov

Dr. Sergey G. Arkhipov

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2018 in CrystEngComm
Verified
Journal Article
Open access
PDF file
NBNadia Bouvart
Nadia Bouvart
RPRoland-Marie Palix
Roland-Marie Palix
SASergey G. Arkhipov
Sergey G. Arkhipov
ITIvan A. Tumanov
Ivan A. Tumanov
Adam MichalchukAdam Michalchuk
Adam Michalchuk
Elena BoldyrevaElena Boldyreva
Elena Boldyreva
Different types of mechanical treatment (tableting, grinding, milling, etc.) are important technological operations in the pharmaceutical industry. Solid materials are not merely comminuted during such treatment, but can undergo polymorphic transitions and amorphisation. A liquid is often added to the solid sample on purpose, e.g. in order to facilitate comminution. In many cases, liquid is present inadvertently, either as a result of trace solvent following up-stream operations, or sorbed from the atmosphere. This work explores the liquid-assisted mechanical treatment of two metastable forms of a model pharmaceutical compound chlorpropamide (CPA), namely the β- and ε-forms. We investigate the stability of these polymorphs to mechanical treatment in the presence of a series of fluids that have affinity for different fragments of the CPA molecule. In addition to variation in fluids, the effect of different mechanical treatment is explored, employing model shear and restricted impact devices, alongside grinding in a mortar. CPA offers a clear example of the drastically different results of shear and impact on mechanochemical polymorphism, on the importance of the careful selection of solvent for liquid-assisted treatment, and on the possible role of even trace quantities of solvent. Further, this work demonstrates the importance of the starting polymorph in determining the outcome of a mechanochemical process. All of these factors can have notable consequence on the outcome of technological operations that include mechanical treatment.


4 September 2015 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
Elena BoldyrevaElena Boldyreva
Elena Boldyreva
SASergey G. Arkhipov
Sergey G. Arkhipov
TDTatiana N. Drebushchak
Tatiana N. Drebushchak
VDValeri A. Drebushchak
Valeri A. Drebushchak
ELEvgeniy A. Losev
Evgeniy A. Losev
BZBoris A. Zakharov
Boris A. Zakharov

25 January 2022 in CrystEngComm
Verified
Journal Article
Closed access
PDF file
ELEvgeniy Losev
Evgeniy Losev
SASergey G. Arkhipov
Sergey G. Arkhipov
DKDmitry Sergeevich Kolybalov
Dmitry Sergeevich Kolybalov
AMAlexey Mineev
Alexey Mineev
AOAndrey G. Ogienko
Andrey G. Ogienko
VBVladimir Boldyrev
Vladimir Boldyrev
Usually, in situ diffraction studies of mechanochemical transformations use plastic milling jars in place of steel. This is done to reduce the absorption of radiation by the walls. Using the polymorphic transformation of β-glycine as an example, we show that the transformation rate can vary significantly depending on the material of the jars. Using ex situ analysis we here compare the transformation rates using steel and common plastics such as acrylonitrile butadiene styrene, polylactic acid, and polyethylene terephthalate glycol.

20 January 2024 in Computation
Verified
Journal Article
Open access
PDF file
DKDmitry Sergeevich Kolybalov
Dmitry Sergeevich Kolybalov
EKEvgenii Dmitrievich Kadtsyn
Evgenii Dmitrievich Kadtsyn
SASergey G. Arkhipov
Sergey G. Arkhipov
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) virus syndrome caused the recent outbreak of COVID-19 disease, the most significant challenge to public health for decades. Despite the successful development of vaccines and promising therapies, the development of novel drugs is still in the interests of scientific society. SARS-CoV-2 main protease Mpro is one of the key proteins for the lifecycle of the virus and is considered an intriguing target. We used a structure-based drug design approach as a part of the search of new inhibitors for SARS-CoV-2 Mpro and hence new potential drugs for treating COVID-19. Four structures of potential inhibitors of (4S)-2-(2-(1H-imidazol-5-yl)ethyl)-4-amino-2-(1,3-dihydroxypropyl)-3-hydroxy-5-(1H-imidazol-5-yl)pentanal (L1), (2R,4S)-2-((1H-imidazol-4-yl)methyl)-4-chloro-8-hydroxy-7-(hydroxymethyl)octanoic acid (L2), 1,9-dihydroxy-6-(hydroxymethyl)-6-(((1S)-1,7,7-trimethylbicyclo [2.2.1]heptan-2-yl)amino)nonan-4-one (L3), and 2,4,6-tris((4H-1,2,4-triazol-3-yl)amino)benzonitrile (L4) were modeled. Three-dimensional structures of ligand–protein complexes were modeled and their potential binding efficiency proved. Docking and molecular dynamic simulations were performed for these compounds. Detailed trajectory analysis of the ligands’ binding conformation was carried out. Binding free energies were estimated by the MM/PBSA approach. Results suggest a high potential efficiency of the studied inhibitors.

30 January 2016 in Acta crystallographica Section B, Structural science, crystal engineering and materials
Verified
Journal Article
Closed access
PDF file
DRDenis Rychkov
Denis Rychkov
SASergey G. Arkhipov
Sergey G. Arkhipov
EBElena Boldyreva
Elena Boldyreva